6Lazzaroni M, Porro GB. Preparation, premedication, and surveillance[J]. Endoscopy,2005,37(2) : 101-109. 被引量：1
7Qadeer MA, Vargo JJ, Khandwala F, et al. Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis[J]. Clin Gastroenterol Hepatol, 2005, 3 ( 11 ) :1049-1056. 被引量：1
8Heuss LT, Froehlich F, Beglinger C. Changing patterns of sedation and monitoring practice during endoscopy: results of a nationwide survey in Switzerland [J ]. Endoscopy, 2005,3 , ( 2 ) :161-166. 被引量：1
9Machotta A. Anaesthetic management for endoscopy of the pediatric airway [J]. Anaesthesist,2002,51 (8) : 668-678. 被引量：1
10Radaelli F, Terruzzi V, Minoli G. Extended/advanced monitoring techniques in gastrointestinal endoscopy [ J ]. Gastrointest Endosc Clin N Am,2004,14(2):335-352. 被引量：1
3Gharagozlou P, Hashemi E, Delorey T M, et al.Pharmacological profiles of opioid ligands at kappa opioid receptors[J].BMC Pharmacol, 2006, 6(1):3. 被引量：1
4Picher M J.Discriminative stimulus effects of the mixed-opioid agonist/ antagonist dezocine: cross-substitution by mu and delta opioid agonists[J].J Pharmacol Exp Ther, 1997:283 ( 3 ) : 1009-1017. 被引量：1
5I Herrera-Peeo I, Wix-Ramos：R, Domfnguez-Gadea L, et al.Changes in cerebral perfusion induced by etomidate in patients with temporal lobe epilepsy[J].Rev Neurol, 2009, 49 ( 11 ) : 561-565. 被引量：1
6Morton N,Johnson G,White M,et al.Propofol in paediatric[J].Anaesthesia,1992,2(1):89-97. 被引量：1
7Vuyk J.Clinical interpretation of pharmacokinetic and pharmacodynamic propofol-opioid interactions[J].Acta Anaesthesiol Belg,2001,52(4):445. 被引量：1
8Mi W,Sakai T,Kudo M.The interaction fentanyl and propofol during emergence from anesthesia:monitoring with the EEG-Bispectral index[J].Clin Anesth,2003,15(2):103. 被引量：1
9Z. P. Khan,C. N. Ferguson,R. M. Jones.Alpha‐2 and imidazoline receptor agonistsTheir pharmacology and therapeutic role[J]. Anaesthesia . 2002 (2) 被引量：4
